Cocrystal Pharma (COCP) Depreciation & Amortization (CF) (2010 - 2026)
Cocrystal Pharma (COCP) posted Depreciation & Amortization (CF) of $12000.0 for Q1 2026, down 7.69% sequentially from $13000.0 in Q4 2025, and down 52.0% YoY from $25000.0 in Q1 2025.
Cocrystal Pharma (COCP) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Cocrystal Pharma has reported Depreciation & Amortization (CF) for 16 years, with the latest figure at $12000.0 in Q1 2026.
- Quarterly Depreciation & Amortization (CF) fell 52.0% year-over-year to $12000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $59000.0 (down 49.14% YoY) and the FY2025 annual result came in at $72000.0, down 42.86% from the prior year.
- Depreciation & Amortization (CF) retreated to $12000.0 in Q1 2026 per COCP's latest filing, from $13000.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $53000.0 in Q3 2023 and troughed at $12000.0 in Q1 2026.
- A 5-year average of $34352.9 and a median of $35000.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2023 and 2025: Depreciation & Amortization (CF) gained 12.77% in 2023, then slumped 56.67% in 2025.
- Over 5 years, Depreciation & Amortization (CF) stood at $48000.0 in 2022, then fell by 16.67% to $40000.0 in 2023, then fell by 30.0% to $28000.0 in 2024, then plunged by 53.57% to $13000.0 in 2025, then slipped by 7.69% to $12000.0 in 2026.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $12000.0, $13000.0, and $13000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 40.52 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 191.83 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Cocrystal Pharma | 15.65 Mn | 13.33 Mn | - | 12,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12,000.00 |
| Jun 30, 2026 | 12,000.00 |
| Mar 31, 2026 | 12,000.00 |
| Mar 31, 2026 | 12,000.00 |
| Dec 31, 2025 | 13,000.00 |
| Dec 31, 2025 | 13,000.00 |
| Sep 30, 2025 | 13,000.00 |
| Sep 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 21,000.00 |
| Jun 30, 2025 | 21,000.00 |
| Mar 31, 2025 | 25,000.00 |
| Mar 31, 2025 | 25,000.00 |
| Dec 31, 2024 | 28,000.00 |
| Dec 31, 2024 | 28,000.00 |
| Sep 30, 2024 | 30,000.00 |
| Sep 30, 2024 | 30,000.00 |
| Jun 30, 2024 | 33,000.00 |
| Jun 30, 2024 | 33,000.00 |
| Mar 31, 2024 | 35,000.00 |
| Mar 31, 2024 | 35,000.00 |